Genetics of cancer therapy-induced cardiomyopathy

被引：0
|
作者：
Huynh, Karina
机构：
[1] Nature Reviews Cardiology,
来源：
NATURE REVIEWS CARDIOLOGY | 2019年 / 16卷 / 07期
关键词：
D O I：
10.1038/s41569-019-0204-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Patients with chemotherapy-induced cardiomyopathy have a high prevalence of rare variants of cardiomyopathy-related genes, in particular titin-truncating variants.
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [1] Genetics of cancer therapy-induced cardiomyopathy
    Karina Huynh
    Nature Reviews Cardiology, 2019, 16 : 384 - 385
  • [2] Genetic Background in Patients with Cancer Therapy-Induced Cardiomyopathy
    Fazzini, Luca
    Campana, Nicola
    Cossu, Stefano
    Deidda, Martino
    Madaudo, Cristina
    Quagliariello, Vincenzo
    Maurea, Nicola
    Di Lisi, Daniela
    Novo, Giuseppina
    Zito, Concetta
    Dessalvi, Christian Cadeddu
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [3] Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy
    Garcia-Pavia, Pablo
    Kim, Yuri
    Alejandra Restrepo-Cordoba, Maria
    Lunde, Ida G.
    Wakimoto, Hiroko
    Smith, Amanda M.
    Toepfer, Christopher N.
    Getz, Kelly
    Gorham, Joshua
    Patel, Parth
    Ito, Kaoru
    Willcox, Jonathan A.
    Arany, Zoltan
    Li, Jian
    Owens, Anjali T.
    Govind, Risha
    Nunez, Beatriz
    Mazaika, Erica
    Bayes-Genis, Antoni
    Walsh, Roddy
    Finkelman, Brian
    Lupon, Josep
    Whiffin, Nicola
    Serrano, Isabel
    Midwinter, William
    Wilk, Alicja
    Bardaji, Alfredo
    Ingold, Nathan
    Buchan, Rachel
    Tayal, Upasana
    Pascual-Figal, Domingo A.
    de Marvao, Antonio
    Ahmad, Mian
    Manuel Garcia-Pinilla, Jose
    Pantazis, Antonis
    Dominguez, Fernando
    Baksi, A. John
    O'Regan, Declan P.
    Rosen, Stuart D.
    Prasad, Sanjay K.
    Lara-Pezzi, Enrique
    Provencio, Mariano
    Lyon, Alexander R.
    Alonso-Pulpon, Luis
    Cook, Stuart A.
    DePalma, Steven R.
    Barton, Paul J. R.
    Aplenc, Richard
    Seidman, Jonathan G.
    Ky, Bonnie
    CIRCULATION, 2019, 140 (01) : 31 - 41
  • [4] Arrhythmias and device therapies in patients with cancer therapy-induced cardiomyopathy
    Lee, Charlotte
    Maan, Abhishek
    Singh, Jagmeet P.
    Fradley, Michael G.
    HEART RHYTHM, 2021, 18 (07) : 1223 - 1229
  • [5] Myocardial function and structure improvement with sacubitril/valsartan in cancer therapy-induced cardiomyopathy
    Martin-Garcia, Ana
    Diaz-Pelaez, Elena
    Martin-Garcia, Agustin C.
    Sanchez-Gonzalez, Javier
    Ibanez, Borja
    Sanchez, Pedro L.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2020, 73 (03): : 268 - 269
  • [6] Therapy-Induced Senescence in Cancer
    Ewald, Jonathan A.
    Desotelle, Joshua A.
    Wilding, George
    Jarrard, David F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (20): : 1536 - 1546
  • [7] Cancer Therapy-Induced Encephalitis
    Desbaillets, Nicolas P.
    Hottinger, Andreas F.
    CANCERS, 2024, 16 (21)
  • [8] Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it?
    Stack, Jonathan P.
    Moslehi, Javid
    Sayed, Nazish
    Wu, Joseph C.
    EUROPEAN HEART JOURNAL, 2019, 40 (22) : 1764 - 1770
  • [9] Therapy-induced microenvironmental changes in cancer
    Yuting Ma
    Heng Yang
    Jonathan M. Pitt
    Guido Kroemer
    Laurence Zitvogel
    Journal of Molecular Medicine, 2016, 94 : 497 - 508
  • [10] Update on cancer therapy-induced atherosclerosis
    Reeves, David J.
    Rao, Vijay U.
    CURRENT OPINION IN CARDIOLOGY, 2022, 37 (04) : 372 - 379
12345